2016 MASCC and ESMO Guideline Update for the Prevention of Chemotherapy- and Radiotherapy-induced Nausea and Vomiting and of Nausea and Vomiting in Advanced Cancer Patients

A clinical practice guideline for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in advanced cancer patients. The guideline examines the emetogenic potential of antineoplastic agents and recommended pharmacological treatments. Outcomes of interest include antiemetic prophylaxis, efficacy, and optimal dosing.